Endogenous Glucocorticoid Receptor Activation Modulates Early-Stage Cell Differentiation in Pancreatic Progenitors of Mice and Humans
Ontology highlight
ABSTRACT: Understanding the pancreatic developmental process is instrumental to tackle diabetes, allowing improvements of in vitro differentiation protocols aimed at producing of functional β-cells for transplantation. Here, we investigate the role of Glucocorticoid Receptor (GR) signaling in the earliest stages of pancreas development decisions in both mice and humans. Previous reports suggest that glucocorticoids do not play a significant role in mouse pancreas development before the second transition. In this study, we demonstrate that, under physiological conditions, the GR is selectively active in pro-acinar cells of the mouse embryonic pancreas from E11.5 and on. It is silenced in early-stage bipotent and endocrine progenitors, and its expression is reactivated upon endocrine commitment. Ectopic GR activation in mouse pancreatic explants globally commits progenitors to the acinar lineage. In sharp contrast, GR activation in in vitro-derived human pancreatic multipotent progenitors promotes commitment to the endocrine lineage, inducing the expression of novel genes associated with human embryonic pancreatic bipotential and endocrine progenitors. A combined epigenomic and single-cell transcriptomic screen suggests that these novel marker genes could play important roles in human pancreas development. Taken together, our findings position the GR pathway as an endogenous developmental modulator of early-stage pancreatic progenitor cell differentiation. We also demonstrate that glucocorticoids can bias in vitro-derived human pancreatic progenitor cell commitment toward the endocrine lineage and provide insights into the underlying transcriptional mechanisms potentially involved.
ORGANISM(S): Homo sapiens
PROVIDER: GSE237280 | GEO | 2025/04/30
REPOSITORIES: GEO
ACCESS DATA